

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.23572130 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.41942330 |
| 3 | actin filament-based movement (GO:0030048) | 7.50411898 |
| 4 | plasma membrane repair (GO:0001778) | 7.41582587 |
| 5 | myotube cell development (GO:0014904) | 7.08698526 |
| 6 | creatine metabolic process (GO:0006600) | 6.74468292 |
| 7 | skeletal muscle tissue regeneration (GO:0043403) | 6.73188730 |
| 8 | striated muscle contraction (GO:0006941) | 6.69460407 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.61895919 |
| 10 | sarcomere organization (GO:0045214) | 6.50293491 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.28967007 |
| 12 | glycogen catabolic process (GO:0005980) | 6.16949087 |
| 13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.13297248 |
| 14 | cytidine metabolic process (GO:0046087) | 5.97435444 |
| 15 | cytidine catabolic process (GO:0006216) | 5.97435444 |
| 16 | cytidine deamination (GO:0009972) | 5.97435444 |
| 17 | purine nucleotide salvage (GO:0032261) | 5.91694796 |
| 18 | carnitine shuttle (GO:0006853) | 5.86786409 |
| 19 | glucan catabolic process (GO:0009251) | 5.75989646 |
| 20 | myofibril assembly (GO:0030239) | 5.68137740 |
| 21 | muscle contraction (GO:0006936) | 5.62302399 |
| 22 | cellular polysaccharide catabolic process (GO:0044247) | 5.32003436 |
| 23 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.28392553 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.28006786 |
| 25 | response to muscle activity (GO:0014850) | 5.27086633 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.19965099 |
| 27 | striated muscle atrophy (GO:0014891) | 5.17772132 |
| 28 | response to inactivity (GO:0014854) | 5.12609898 |
| 29 | polysaccharide catabolic process (GO:0000272) | 5.03726041 |
| 30 | muscle system process (GO:0003012) | 4.94539369 |
| 31 | muscle fiber development (GO:0048747) | 4.94472967 |
| 32 | glucan biosynthetic process (GO:0009250) | 4.91873558 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.91873558 |
| 34 | striated muscle adaptation (GO:0014888) | 4.91250292 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 4.84088958 |
| 36 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.81406337 |
| 37 | IMP metabolic process (GO:0046040) | 4.72857517 |
| 38 | fructose metabolic process (GO:0006000) | 4.72207272 |
| 39 | gluconeogenesis (GO:0006094) | 4.72059375 |
| 40 | carnitine transmembrane transport (GO:1902603) | 4.66023872 |
| 41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.55546050 |
| 42 | actomyosin structure organization (GO:0031032) | 4.52589208 |
| 43 | 2-oxoglutarate metabolic process (GO:0006103) | 4.50072649 |
| 44 | muscle organ morphogenesis (GO:0048644) | 4.44426963 |
| 45 | muscle atrophy (GO:0014889) | 4.36699933 |
| 46 | amino-acid betaine transport (GO:0015838) | 4.36373731 |
| 47 | carnitine transport (GO:0015879) | 4.36373731 |
| 48 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.33554323 |
| 49 | hexose biosynthetic process (GO:0019319) | 4.30568161 |
| 50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.28370299 |
| 51 | glycogen metabolic process (GO:0005977) | 4.27884039 |
| 52 | cellular glucan metabolic process (GO:0006073) | 4.18826084 |
| 53 | glucan metabolic process (GO:0044042) | 4.18826084 |
| 54 | neuronal action potential propagation (GO:0019227) | 4.13275927 |
| 55 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.06717324 |
| 56 | cardiac muscle hypertrophy (GO:0003300) | 4.04947194 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 4.00224416 |
| 58 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.99908801 |
| 59 | muscle organ development (GO:0007517) | 3.92975094 |
| 60 | muscle structure development (GO:0061061) | 3.89767516 |
| 61 | muscle adaptation (GO:0043500) | 3.88866201 |
| 62 | response to activity (GO:0014823) | 3.86677609 |
| 63 | striated muscle hypertrophy (GO:0014897) | 3.86240615 |
| 64 | ubiquinone biosynthetic process (GO:0006744) | 3.86199530 |
| 65 | regulation of cofactor metabolic process (GO:0051193) | 3.85166364 |
| 66 | regulation of coenzyme metabolic process (GO:0051196) | 3.85166364 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 3.85097097 |
| 68 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.84835106 |
| 69 | cardiac muscle contraction (GO:0060048) | 3.83157516 |
| 70 | muscle cell fate commitment (GO:0042693) | 3.81083501 |
| 71 | monosaccharide biosynthetic process (GO:0046364) | 3.79115782 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 3.74299811 |
| 73 | cellular carbohydrate catabolic process (GO:0044275) | 3.74054338 |
| 74 | IMP biosynthetic process (GO:0006188) | 3.70654017 |
| 75 | striated muscle cell development (GO:0055002) | 3.70536902 |
| 76 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.67657455 |
| 77 | regulation of relaxation of muscle (GO:1901077) | 3.66143438 |
| 78 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.59952344 |
| 79 | muscle tissue morphogenesis (GO:0060415) | 3.54964023 |
| 80 | muscle cell cellular homeostasis (GO:0046716) | 3.50273063 |
| 81 | ubiquinone metabolic process (GO:0006743) | 3.46085415 |
| 82 | skeletal muscle tissue development (GO:0007519) | 3.44722897 |
| 83 | negative regulation of muscle hypertrophy (GO:0014741) | 3.41121769 |
| 84 | muscle hypertrophy (GO:0014896) | 3.40008069 |
| 85 | otic vesicle formation (GO:0030916) | 3.39591738 |
| 86 | oxidative phosphorylation (GO:0006119) | 3.39314722 |
| 87 | adult heart development (GO:0007512) | 3.39287596 |
| 88 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.38656496 |
| 89 | NADH metabolic process (GO:0006734) | 3.36548634 |
| 90 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.33139604 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 3.32404591 |
| 92 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.30912114 |
| 93 | neuromuscular junction development (GO:0007528) | 3.28370553 |
| 94 | regulation of sulfur metabolic process (GO:0042762) | 3.26815046 |
| 95 | regulation of actin filament-based movement (GO:1903115) | 3.26416724 |
| 96 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.24296326 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.20375106 |
| 98 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.20375106 |
| 99 | quinone biosynthetic process (GO:1901663) | 3.19394239 |
| 100 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.19034948 |
| 101 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.19034948 |
| 102 | skeletal muscle cell differentiation (GO:0035914) | 3.17937863 |
| 103 | regulation of myoblast differentiation (GO:0045661) | 3.16959654 |
| 104 | quaternary ammonium group transport (GO:0015697) | 3.16033080 |
| 105 | cardiac myofibril assembly (GO:0055003) | 3.15830746 |
| 106 | muscle cell development (GO:0055001) | 3.15396978 |
| 107 | negative regulation of muscle contraction (GO:0045932) | 3.15102887 |
| 108 | myotube differentiation (GO:0014902) | 3.14877701 |
| 109 | regulation of striated muscle contraction (GO:0006942) | 3.13990665 |
| 110 | cardiac muscle adaptation (GO:0014887) | 3.13402787 |
| 111 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.13402787 |
| 112 | muscle hypertrophy in response to stress (GO:0003299) | 3.13402787 |
| 113 | glycolytic process (GO:0006096) | 3.08426930 |
| 114 | myoblast fusion (GO:0007520) | 3.07318872 |
| 115 | AMP metabolic process (GO:0046033) | 3.06251156 |
| 116 | cellular response to dexamethasone stimulus (GO:0071549) | 3.05829617 |
| 117 | regulation of sequestering of triglyceride (GO:0010889) | 3.04768597 |
| 118 | striated muscle tissue development (GO:0014706) | 3.02317874 |
| 119 | cardiac cell development (GO:0055006) | 3.01259247 |
| 120 | cellular carbohydrate biosynthetic process (GO:0034637) | 2.98976588 |
| 121 | cardiac muscle cell development (GO:0055013) | 2.96969640 |
| 122 | regulation of membrane repolarization (GO:0060306) | 2.90289665 |
| 123 | muscle filament sliding (GO:0030049) | 12.3474398 |
| 124 | actin-myosin filament sliding (GO:0033275) | 12.3474398 |
| 125 | regulation of skeletal muscle contraction (GO:0014819) | 11.8546774 |
| 126 | skeletal muscle contraction (GO:0003009) | 11.3968482 |
| 127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.3490368 |
| 128 | actin-mediated cell contraction (GO:0070252) | 10.1246149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.60430598 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29127432 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.60706311 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.40606036 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.36332757 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.96137751 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52283061 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.52148925 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.52148925 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44154536 |
| 11 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.43269705 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.36326658 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.26264459 |
| 14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25998851 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.21463091 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16554498 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09724507 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06314438 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.04992916 |
| 20 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.96817523 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.89135692 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86497441 |
| 23 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.84217417 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81669758 |
| 25 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.79851034 |
| 26 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.77488126 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74117658 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.70813265 |
| 29 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70443694 |
| 30 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.62070163 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.57376558 |
| 32 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.57351964 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51919146 |
| 34 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.47990360 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46792480 |
| 36 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.45976484 |
| 37 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.43474963 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43056879 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42691603 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42506841 |
| 41 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.42475729 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42189146 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42178574 |
| 44 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.38105140 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36395391 |
| 46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36288953 |
| 47 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35848076 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33723346 |
| 49 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29919204 |
| 50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29666072 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29131786 |
| 52 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.26315329 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.26292106 |
| 54 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25517510 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24691156 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.24548410 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22399223 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21187191 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20967681 |
| 60 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.20581241 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20118773 |
| 62 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.18115449 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17553532 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17057884 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16659686 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16289810 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15918453 |
| 68 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.15141398 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14602103 |
| 70 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14511823 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14231003 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13729608 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.12362359 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10523035 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09460073 |
| 76 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.08906309 |
| 77 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.08782412 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08620317 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08105231 |
| 80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07996359 |
| 81 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07564738 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07397735 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06711116 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06363739 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05988867 |
| 86 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.05592540 |
| 87 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.05434968 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05413402 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04030036 |
| 90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.03949496 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02921204 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02634178 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02275697 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02183442 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01777259 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01346754 |
| 97 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00792887 |
| 98 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99944725 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99534357 |
| 100 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99508875 |
| 101 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99162458 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99143786 |
| 103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97917551 |
| 104 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.97248021 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96874752 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96586743 |
| 107 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.96458838 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96263437 |
| 109 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95270490 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95131863 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95131863 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93383294 |
| 113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93315636 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93171902 |
| 115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92996331 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92681418 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92651350 |
| 118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92597304 |
| 119 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92456064 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91962061 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91949450 |
| 122 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.91782592 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.91346928 |
| 124 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.90885538 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90810636 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90791484 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90096955 |
| 128 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.89908117 |
| 129 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.88563970 |
| 130 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88542888 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88378241 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88346484 |
| 133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88345147 |
| 134 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.88344794 |
| 135 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87848529 |
| 136 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87565857 |
| 137 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85735180 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85490237 |
| 139 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84989021 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83901775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.97406816 |
| 2 | MP0003646_muscle_fatigue | 6.85641985 |
| 3 | MP0000749_muscle_degeneration | 6.20259967 |
| 4 | MP0000751_myopathy | 5.54888528 |
| 5 | MP0000747_muscle_weakness | 4.51707621 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.16660969 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.12966703 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.72193286 |
| 9 | MP0002269_muscular_atrophy | 3.57009183 |
| 10 | MP0005369_muscle_phenotype | 3.47274269 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.41312388 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.27089812 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.25120033 |
| 14 | MP0004130_abnormal_muscle_cell | 3.15991121 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.03084461 |
| 16 | MP0004233_abnormal_muscle_weight | 2.85047844 |
| 17 | MP0000733_abnormal_muscle_development | 2.34593521 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.01356525 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 1.98326999 |
| 20 | MP0005330_cardiomyopathy | 1.95638331 |
| 21 | MP0002108_abnormal_muscle_morphology | 1.94393325 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.85954606 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.65521876 |
| 24 | MP0000013_abnormal_adipose_tissue | 1.52018048 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.47516051 |
| 26 | MP0004270_analgesia | 1.45763116 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.45564073 |
| 28 | MP0002971_abnormal_brown_adipose | 1.42418756 |
| 29 | MP0004484_altered_response_of | 1.40030312 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.34220022 |
| 31 | MP0001661_extended_life_span | 1.25679725 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.25628182 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22749387 |
| 34 | MP0002972_abnormal_cardiac_muscle | 1.21837956 |
| 35 | MP0010630_abnormal_cardiac_muscle | 1.17100340 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.16894696 |
| 37 | MP0002822_catalepsy | 1.11837892 |
| 38 | MP0004043_abnormal_pH_regulation | 1.08676126 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.04324230 |
| 40 | MP0005266_abnormal_metabolism | 0.95364472 |
| 41 | MP0010030_abnormal_orbit_morphology | 0.92723732 |
| 42 | MP0008961_abnormal_basal_metabolism | 0.92411939 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 0.91736640 |
| 44 | MP0005385_cardiovascular_system_phenoty | 0.91736640 |
| 45 | MP0004510_myositis | 0.89312287 |
| 46 | MP0000762_abnormal_tongue_morphology | 0.82211105 |
| 47 | MP0003950_abnormal_plasma_membrane | 0.82003045 |
| 48 | MP0000003_abnormal_adipose_tissue | 0.81127237 |
| 49 | MP0004134_abnormal_chest_morphology | 0.79762097 |
| 50 | MP0009250_abnormal_appendicular_skeleto | 0.77242686 |
| 51 | MP0003137_abnormal_impulse_conducting | 0.76030841 |
| 52 | MP0002089_abnormal_postnatal_growth/wei | 0.71461837 |
| 53 | MP0004147_increased_porphyrin_level | 0.69971393 |
| 54 | MP0000372_irregular_coat_pigmentation | 0.69366147 |
| 55 | MP0001346_abnormal_lacrimal_gland | 0.66126357 |
| 56 | MP0005670_abnormal_white_adipose | 0.62141781 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 0.60165144 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 0.59255519 |
| 59 | MP0006138_congestive_heart_failure | 0.58621099 |
| 60 | MP0008569_lethality_at_weaning | 0.57547258 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.54245717 |
| 62 | MP0003195_calcinosis | 0.52024720 |
| 63 | MP0000343_altered_response_to | 0.51479771 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.50635596 |
| 65 | MP0000266_abnormal_heart_morphology | 0.49421579 |
| 66 | MP0001299_abnormal_eye_distance/ | 0.49360620 |
| 67 | MP0005334_abnormal_fat_pad | 0.48422883 |
| 68 | MP0004142_abnormal_muscle_tone | 0.47620875 |
| 69 | MP0000678_abnormal_parathyroid_gland | 0.46700781 |
| 70 | MP0003828_pulmonary_edema | 0.46521603 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.45881842 |
| 72 | MP0005452_abnormal_adipose_tissue | 0.45759349 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.45672719 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 0.42617329 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.41835421 |
| 76 | MP0000383_abnormal_hair_follicle | 0.40646634 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.40165646 |
| 78 | MP0001529_abnormal_vocalization | 0.40094777 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.37806402 |
| 80 | MP0004858_abnormal_nervous_system | 0.37067673 |
| 81 | MP0003045_fibrosis | 0.35288289 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.35065046 |
| 83 | MP0003941_abnormal_skin_development | 0.34569961 |
| 84 | MP0009672_abnormal_birth_weight | 0.33659833 |
| 85 | MP0003948_abnormal_gas_homeostasis | 0.30692388 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.30522518 |
| 87 | MP0003879_abnormal_hair_cell | 0.30396482 |
| 88 | MP0003123_paternal_imprinting | 0.29391148 |
| 89 | MP0004197_abnormal_fetal_growth/weight/ | 0.29214934 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.28680037 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 0.28535481 |
| 92 | MP0009840_abnormal_foam_cell | 0.28274924 |
| 93 | MP0005083_abnormal_biliary_tract | 0.27771858 |
| 94 | MP0009115_abnormal_fat_cell | 0.26092786 |
| 95 | MP0005332_abnormal_amino_acid | 0.25547401 |
| 96 | MP0001849_ear_inflammation | 0.25513051 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.25468113 |
| 98 | MP0003878_abnormal_ear_physiology | 0.25468113 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.25372170 |
| 100 | MP0008260_abnormal_autophagy | 0.25334162 |
| 101 | MP0003959_abnormal_lean_body | 0.24368893 |
| 102 | MP0001440_abnormal_grooming_behavior | 0.23707294 |
| 103 | MP0002734_abnormal_mechanical_nocicepti | 0.23649392 |
| 104 | MP0001727_abnormal_embryo_implantation | 0.23524787 |
| 105 | MP0005451_abnormal_body_composition | 0.22908146 |
| 106 | MP0001730_embryonic_growth_arrest | 0.22850412 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.22246667 |
| 108 | MP0005535_abnormal_body_temperature | 0.22178564 |
| 109 | MP0009697_abnormal_copulation | 0.22127317 |
| 110 | MP0001943_abnormal_respiration | 0.22000627 |
| 111 | MP0001853_heart_inflammation | 0.21912325 |
| 112 | MP0005187_abnormal_penis_morphology | 0.21700872 |
| 113 | MP0002128_abnormal_blood_circulation | 0.20709138 |
| 114 | MP0003755_abnormal_palate_morphology | 0.20627040 |
| 115 | MP0004085_abnormal_heartbeat | 0.20594313 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.20379522 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.19148128 |
| 118 | MP0009703_decreased_birth_body | 0.18767047 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.18749425 |
| 120 | MP0008770_decreased_survivor_rate | 0.18311659 |
| 121 | MP0002638_abnormal_pupillary_reflex | 0.17885396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.92189321 |
| 2 | Nemaline bodies (HP:0003798) | 9.48665264 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.68795821 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.64880917 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.54542290 |
| 6 | Myopathic facies (HP:0002058) | 7.15497965 |
| 7 | Distal arthrogryposis (HP:0005684) | 6.95553813 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.76178889 |
| 9 | Round ear (HP:0100830) | 6.09223976 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 5.89089223 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.86331478 |
| 12 | Difficulty running (HP:0009046) | 5.49958432 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.43018985 |
| 14 | Calcaneovalgus deformity (HP:0001848) | 5.10694947 |
| 15 | Myoglobinuria (HP:0002913) | 5.01750320 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.87048202 |
| 17 | Muscle stiffness (HP:0003552) | 4.72483179 |
| 18 | Deformed tarsal bones (HP:0008119) | 4.70748510 |
| 19 | Absent phalangeal crease (HP:0006109) | 4.60987672 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.47150733 |
| 21 | Rhabdomyolysis (HP:0003201) | 4.31488541 |
| 22 | Increased connective tissue (HP:0009025) | 4.19969070 |
| 23 | Myotonia (HP:0002486) | 4.03243916 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.90636495 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 3.90101206 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.79079243 |
| 27 | Neck muscle weakness (HP:0000467) | 3.57900029 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.56201888 |
| 29 | Difficulty climbing stairs (HP:0003551) | 3.55921744 |
| 30 | Subaortic stenosis (HP:0001682) | 3.46396096 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.46396096 |
| 32 | Malignant hyperthermia (HP:0002047) | 3.44437741 |
| 33 | Areflexia of lower limbs (HP:0002522) | 3.43160020 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 3.34603151 |
| 35 | Pelvic girdle muscle weakness (HP:0003749) | 3.18093880 |
| 36 | Frequent falls (HP:0002359) | 3.13251634 |
| 37 | Shoulder girdle muscle weakness (HP:0003547) | 3.12272695 |
| 38 | Hyperkalemia (HP:0002153) | 3.06547186 |
| 39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.05767788 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.05767788 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 3.04037072 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.87938824 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.69115374 |
| 44 | Abnormality of the neuromuscular junction (HP:0003398) | 2.60621256 |
| 45 | Fatigable weakness (HP:0003473) | 2.60621256 |
| 46 | Paralysis (HP:0003470) | 2.60202240 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.52190725 |
| 48 | Sudden death (HP:0001699) | 2.51034814 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.43611672 |
| 50 | Slender build (HP:0001533) | 2.34690120 |
| 51 | Proximal amyotrophy (HP:0007126) | 2.33857548 |
| 52 | Muscular dystrophy (HP:0003560) | 2.32212198 |
| 53 | Generalized muscle weakness (HP:0003324) | 2.29111811 |
| 54 | Bulbar palsy (HP:0001283) | 2.22696747 |
| 55 | Nonprogressive disorder (HP:0003680) | 2.21483343 |
| 56 | Limb-girdle muscle weakness (HP:0003325) | 2.21382401 |
| 57 | Facial diplegia (HP:0001349) | 2.21214248 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17626087 |
| 59 | Gowers sign (HP:0003391) | 2.15346362 |
| 60 | Ragged-red muscle fibers (HP:0003200) | 2.08849322 |
| 61 | Weak cry (HP:0001612) | 2.03760128 |
| 62 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02790153 |
| 63 | Spinal rigidity (HP:0003306) | 2.00754231 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 10.4644445 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97397297 |
| 66 | Abnormality of the foot musculature (HP:0001436) | 1.95499559 |
| 67 | Gout (HP:0001997) | 1.93028791 |
| 68 | Scapular winging (HP:0003691) | 1.91908674 |
| 69 | Ulnar deviation of finger (HP:0009465) | 1.90454396 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 1.90305090 |
| 71 | Hypoplastic ischia (HP:0003175) | 1.88505289 |
| 72 | Metatarsus adductus (HP:0001840) | 1.87491004 |
| 73 | Increased intramyocellular lipid droplets (HP:0012240) | 1.87331698 |
| 74 | Lower limb amyotrophy (HP:0007210) | 1.81585533 |
| 75 | Foot dorsiflexor weakness (HP:0009027) | 1.80681138 |
| 76 | Waddling gait (HP:0002515) | 1.80601535 |
| 77 | Fetal akinesia sequence (HP:0001989) | 1.79291848 |
| 78 | Hyperuricemia (HP:0002149) | 1.78331552 |
| 79 | Increased purine levels (HP:0004368) | 1.78331552 |
| 80 | Bundle branch block (HP:0011710) | 1.77403781 |
| 81 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76919594 |
| 82 | Distal lower limb amyotrophy (HP:0008944) | 1.76909495 |
| 83 | Increased muscle lipid content (HP:0009058) | 1.73852090 |
| 84 | Ventricular tachycardia (HP:0004756) | 1.73296263 |
| 85 | Achilles tendon contracture (HP:0001771) | 1.72480000 |
| 86 | Hip contracture (HP:0003273) | 1.69868579 |
| 87 | Short palpebral fissure (HP:0012745) | 1.68300781 |
| 88 | Abnormal atrioventricular conduction (HP:0005150) | 1.64224012 |
| 89 | Popliteal pterygium (HP:0009756) | 1.63001813 |
| 90 | Stridor (HP:0010307) | 1.62300346 |
| 91 | Abnormality of the ischium (HP:0003174) | 1.61171542 |
| 92 | Abnormality of potassium homeostasis (HP:0011042) | 1.58809318 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.56032639 |
| 94 | Increased serum pyruvate (HP:0003542) | 1.53504517 |
| 95 | Type 2 muscle fiber atrophy (HP:0003554) | 1.53478561 |
| 96 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.48896718 |
| 97 | Tarsal synostosis (HP:0008368) | 1.48649483 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.48439482 |
| 99 | Abnormality of glycolysis (HP:0004366) | 1.47974853 |
| 100 | Hyperphosphatemia (HP:0002905) | 1.47148878 |
| 101 | Long clavicles (HP:0000890) | 1.47141734 |
| 102 | Muscle fiber atrophy (HP:0100295) | 1.45388530 |
| 103 | Cholelithiasis (HP:0001081) | 1.43275310 |
| 104 | Lipoatrophy (HP:0100578) | 1.42561800 |
| 105 | Dilated cardiomyopathy (HP:0001644) | 1.42316239 |
| 106 | Ventricular arrhythmia (HP:0004308) | 1.41240989 |
| 107 | Easy fatigability (HP:0003388) | 1.41089430 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.40138687 |
| 109 | Diaphragmatic weakness (HP:0009113) | 1.38488890 |
| 110 | Synostosis involving bones of the feet (HP:0009140) | 1.36994260 |
| 111 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.36994260 |
| 112 | Congenital hip dislocation (HP:0001374) | 1.36001468 |
| 113 | Adducted thumb (HP:0001181) | 1.35648459 |
| 114 | Exercise intolerance (HP:0003546) | 1.35503465 |
| 115 | Acute necrotizing encephalopathy (HP:0006965) | 1.34494290 |
| 116 | Heart block (HP:0012722) | 1.33773255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.89860969 |
| 2 | TTN | 6.18190441 |
| 3 | PHKG1 | 5.17983667 |
| 4 | PHKG2 | 5.17983667 |
| 5 | NME1 | 4.23932466 |
| 6 | PIK3CG | 3.82665546 |
| 7 | PINK1 | 2.61824193 |
| 8 | MAP2K3 | 2.60200966 |
| 9 | PDK3 | 2.57005097 |
| 10 | PDK4 | 2.57005097 |
| 11 | NEK1 | 2.35265923 |
| 12 | MAP3K7 | 1.92918408 |
| 13 | BCKDK | 1.91660191 |
| 14 | TRIB3 | 1.84042214 |
| 15 | PDK2 | 1.78911523 |
| 16 | MUSK | 1.73016519 |
| 17 | DMPK | 1.69938446 |
| 18 | EEF2K | 1.60913620 |
| 19 | MAPK12 | 1.56442868 |
| 20 | MAP2K6 | 1.53305021 |
| 21 | MAP2K4 | 1.38207563 |
| 22 | PIK3CA | 1.38065844 |
| 23 | PRKAA2 | 0.91496840 |
| 24 | PRKAA1 | 0.83217056 |
| 25 | STK24 | 0.82422040 |
| 26 | ZAK | 0.80532275 |
| 27 | MAP3K3 | 0.77913654 |
| 28 | PNCK | 0.73482520 |
| 29 | EPHA2 | 0.72213796 |
| 30 | CAMK2G | 0.71492205 |
| 31 | TAOK2 | 0.71225203 |
| 32 | MARK1 | 0.69187394 |
| 33 | ERBB3 | 0.68990752 |
| 34 | AKT2 | 0.67192140 |
| 35 | VRK2 | 0.63383225 |
| 36 | NEK9 | 0.61750413 |
| 37 | MAPKAPK3 | 0.56269138 |
| 38 | TNIK | 0.55844169 |
| 39 | MAP3K11 | 0.54380841 |
| 40 | CAMK4 | 0.50835486 |
| 41 | MAPK11 | 0.47993593 |
| 42 | ARAF | 0.47583703 |
| 43 | MAP3K13 | 0.46896954 |
| 44 | LATS2 | 0.46303027 |
| 45 | EPHB1 | 0.45211228 |
| 46 | TAOK1 | 0.39852444 |
| 47 | PRKD3 | 0.36682296 |
| 48 | SMG1 | 0.33725173 |
| 49 | TRPM7 | 0.33366079 |
| 50 | PRKACB | 0.32263330 |
| 51 | MAP3K9 | 0.31951495 |
| 52 | CAMK1 | 0.31856597 |
| 53 | CAMK2A | 0.31201905 |
| 54 | PKN2 | 0.31132525 |
| 55 | RIPK1 | 0.29980501 |
| 56 | DYRK3 | 0.29952651 |
| 57 | MAP3K5 | 0.29688326 |
| 58 | PTK6 | 0.28732556 |
| 59 | ILK | 0.28316146 |
| 60 | DYRK1B | 0.27713737 |
| 61 | BRAF | 0.27180900 |
| 62 | CDK19 | 0.26886101 |
| 63 | PRKG1 | 0.26472614 |
| 64 | PRPF4B | 0.26021853 |
| 65 | STK38L | 0.26006998 |
| 66 | ICK | 0.25863164 |
| 67 | MAP3K10 | 0.25802304 |
| 68 | PDPK1 | 0.25134924 |
| 69 | SGK1 | 0.24978344 |
| 70 | MAP2K1 | 0.24659569 |
| 71 | RPS6KB1 | 0.24354124 |
| 72 | MAPK4 | 0.23990531 |
| 73 | SIK1 | 0.23633616 |
| 74 | RPS6KA3 | 0.23543009 |
| 75 | MAPK7 | 0.22128444 |
| 76 | TIE1 | 0.21797239 |
| 77 | MAP3K6 | 0.21403535 |
| 78 | RAF1 | 0.20165844 |
| 79 | PBK | 0.19895380 |
| 80 | PRKACA | 0.19709645 |
| 81 | PDK1 | 0.19579068 |
| 82 | EIF2AK1 | 0.18329310 |
| 83 | BUB1 | 0.18204671 |
| 84 | TGFBR2 | 0.16837981 |
| 85 | TTK | 0.16433344 |
| 86 | MARK3 | 0.15063179 |
| 87 | STK38 | 0.14884489 |
| 88 | CAMK2D | 0.14833982 |
| 89 | PKN1 | 0.14131623 |
| 90 | MAPK13 | 0.12650505 |
| 91 | TBK1 | 0.12587370 |
| 92 | AKT3 | 0.11946306 |
| 93 | STK11 | 0.11823937 |
| 94 | MARK2 | 0.11698400 |
| 95 | MAP2K2 | 0.11691771 |
| 96 | ROCK1 | 0.11037117 |
| 97 | PAK1 | 0.10859054 |
| 98 | MOS | 0.09202046 |
| 99 | KSR2 | 0.08929392 |
| 100 | STK16 | 0.08718114 |
| 101 | PRKD1 | 0.08660979 |
| 102 | GSK3B | 0.07965937 |
| 103 | CSNK2A2 | 0.06409413 |
| 104 | MAPK9 | 0.06239680 |
| 105 | MET | 0.06166015 |
| 106 | CDK1 | 0.05840649 |
| 107 | RPS6KC1 | 0.05377731 |
| 108 | RPS6KL1 | 0.05377731 |
| 109 | CAMK1G | 0.05308173 |
| 110 | MAPK14 | 0.05038021 |
| 111 | LIMK1 | 0.04961656 |
| 112 | MTOR | 0.04486633 |
| 113 | MAPK10 | 0.03466695 |
| 114 | MAPK8 | 0.03400600 |
| 115 | PRKACG | 0.03096283 |
| 116 | PRKCG | 0.02631703 |
| 117 | CDK3 | 0.02405669 |
| 118 | MAP3K1 | 0.02340667 |
| 119 | RPS6KA1 | 0.01491389 |
| 120 | GSK3A | 0.01178803 |
| 121 | SGK3 | 0.01049719 |
| 122 | CSNK1A1 | 0.00926588 |
| 123 | CAMK2B | 0.00916219 |
| 124 | CSNK1D | -0.0461057 |
| 125 | LATS1 | -0.0335545 |
| 126 | PRKCA | -0.0331326 |
| 127 | EIF2AK3 | -0.0307755 |
| 128 | CSNK1E | -0.0303850 |
| 129 | FGFR1 | -0.0181440 |
| 130 | PTK2B | -0.0143904 |
| 131 | PAK6 | -0.0069914 |
| 132 | CCNB1 | -0.0066345 |
| 133 | RPS6KB2 | -0.0027466 |
| 134 | MAP3K8 | -0.0012535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.51167045 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.91905344 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.65076102 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.49912724 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.33312358 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06612255 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.76725895 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.69721603 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.67142041 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.40260101 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.33341019 |
| 12 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.12965244 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.08530957 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07494629 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 1.94016882 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.92994323 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.85560068 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.82050596 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.74447960 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74273248 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70272497 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.68556741 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67178934 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65816287 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64730064 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61731786 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52912912 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52884129 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.51561323 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.50863716 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47979745 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42718139 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38930908 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.36441964 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.30551399 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.28435416 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26233849 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24946493 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17507724 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14708811 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11622923 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09825318 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05048700 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02869661 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99290163 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93366380 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90598685 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88210590 |
| 49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87054772 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84768737 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83204336 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77603806 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77602546 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73238556 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72742300 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72441819 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.70295675 |
| 58 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65144558 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64688938 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59524456 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.57854569 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56623585 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54720494 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54475285 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53456435 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53227013 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.52661826 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49384815 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45633815 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.43224437 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.42550621 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42014786 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.41740805 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41337799 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.40960904 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40041605 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37729360 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36777239 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35894734 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35821481 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35118270 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34539222 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33710810 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33493534 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33321015 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31929549 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31828004 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29683303 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29646126 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29208118 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28803863 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28574478 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27612518 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.27206457 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26401401 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.26064399 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25517678 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24129191 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23723980 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21466774 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20349986 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.20345511 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18394746 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.17557474 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16508668 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15666838 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.15583286 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.15341572 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14478018 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.13683905 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.12892811 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12851921 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12328698 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12164785 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11896680 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10408432 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.09706109 |
| 118 | RNA transport_Homo sapiens_hsa03013 | 0.09248658 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.08890309 |
| 120 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08491482 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.06817213 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06792374 |
| 123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.05849336 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05249527 |

